X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1366) 1366
Publication (22) 22
Patent (10) 10
Book Chapter (3) 3
Conference Proceeding (3) 3
Dissertation (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (654) 654
male (390) 390
female (348) 348
adult (300) 300
middle aged (297) 297
aged (195) 195
oncology (178) 178
hematology (159) 159
animals (132) 132
adolescent (85) 85
mice (78) 78
immunology (75) 75
chemotherapy (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (67) 67
cells, cultured (67) 67
index medicus (66) 66
expression (65) 65
aged, 80 and over (62) 62
lung neoplasms - drug therapy (54) 54
cancer (53) 53
lung neoplasms - pathology (50) 50
molecular sequence data (47) 47
treatment outcome (46) 46
leukemia (40) 40
colony-forming units assay (39) 39
polymerase chain reaction (39) 39
prognosis (39) 39
base sequence (38) 38
cisplatin (38) 38
cell line (37) 37
mutation (37) 37
cisplatin - administration & dosage (36) 36
lung cancer (34) 34
tumor cells, cultured (34) 34
carcinoma, non-small-cell lung - drug therapy (33) 33
cells (33) 33
rats (33) 33
respiratory system (33) 33
gene (31) 31
medicine, general & internal (31) 31
medicine, research & experimental (31) 31
pharmacology & pharmacy (30) 30
transplantation (30) 30
biochemistry & molecular biology (29) 29
dose-response relationship, drug (28) 28
bone marrow cells (27) 27
colony-stimulating factor (27) 27
granulocyte colony-stimulating factor - pharmacology (27) 27
retrospective studies (27) 27
antineoplastic combined chemotherapy protocols - adverse effects (26) 26
enzyme-linked immunosorbent assay (26) 26
g-csf (26) 26
japan (26) 26
acute disease (25) 25
drug administration schedule (25) 25
granulocyte colony-stimulating factor (25) 25
immunophenotyping (25) 25
proliferation (25) 25
recombinant proteins - pharmacology (25) 25
adenocarcinoma (24) 24
amino acid sequence (24) 24
lung neoplasms - mortality (24) 24
non-small cell lung cancer (24) 24
time factors (24) 24
flow cytometry (23) 23
gene expression (23) 23
identification (23) 23
neoplasm staging (23) 23
therapy (23) 23
bone marrow - pathology (22) 22
cell biology (22) 22
carcinoma (21) 21
carcinoma, non-small-cell lung - pathology (21) 21
docetaxel (21) 21
survival analysis (21) 21
cell division - drug effects (20) 20
combined modality therapy (20) 20
growth (20) 20
hematology, oncology and palliative medicine (20) 20
leukemia, myeloid, acute - pathology (20) 20
lupus erythematosus, systemic - immunology (20) 20
medicine & public health (20) 20
survival rate (20) 20
tumors (20) 20
antigens, cd - analysis (19) 19
differentiation (19) 19
hematopoiesis (19) 19
hematopoietic stem cell transplantation (19) 19
hematopoietic stem cells - drug effects (19) 19
receptor (19) 19
research article (19) 19
rheumatology (19) 19
trial (19) 19
tumor-necrosis-factor (19) 19
analysis (18) 18
care and treatment (18) 18
cell division (18) 18
child (18) 18
disease-free survival (18) 18
lupus erythematosus, systemic - complications (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue suppl 11, pp. xi29 - xi34
Journal Article
by Ou, S. I and Camidge, D. R and Engelman, J and Clark, J and Tye, L and Wilner, K and Stephenson, P and Varella-Garcia, M and Iafrate, A and Shaw, A. T and Hainaut, P and Ma, X and Lacas, B and Tsao, M and Douillard, J and Rousseau, V and Dunant, A and Seymour, L and Filipits, M and Graziano, S and He, J and Yang, H and Deng, Q and He, P and Jiang, J and Zhao, M and Gu, X and Zheng, L and Pang, H and Zhou, J. X and Reinmuth, N and Scherer, S. J and Penzel, R and Schnabel, P and Meister, M and Kiemle-Kallee, J and Reuss, A and Fischer, J. R and Wolf, M and Thomas, M and von Laffert, M and Berg, E and Lenze, D and Lohneis, P and Hummel, M and Dietel, M and Han, X and Ma, L and Liu, Y and Zhang, N. N and Li, D and Shi, Y and Furugaki, K and Iwai, T and Moriya, Y and Fujimoto-Ouchi, K and Mok, T. S. K and Park, K and Geater, S. L and Agarwal, S and Han, M and Credi, M and McKee, K and Kuriyama, N and Slichenmyer, W and Tan, E. H and Greillier, L and Martel-Lafay, I and Arpin, D and Pourel, N and Chabaud, S and Lamy, R and Madroszyk, A and Fournel, P and Strom, H. H and Sundstrom, S and Helbekkmo, N and Bremnes, R and Aasebo, U and van Elmpt, W and Ollers, M and Dingemans, A. C and Lambin, P and De Ruysscher, D and Topkan, E and Parlak, C and Topuk, S and Ozyilkan, O and Uyterlinde, W and Vincent, A. D and Belderbos, J and Korse, T and Baas, P and van den Heuvel, M and Satouchi, M and Chiba, Y and Yamamoto, N and Nishimura, Y and Tsujino, K and Fujisaka, Y and ... and on behalf of The Mar-LC Collaborative Group
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix389 - ix399
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue suppl 11, pp. xi99 - xi131
Journal Article
by Nigro, C. L and Monteverde, M and Strola, G and Maffi, M and Miraglio, E and Lattanzio, L and Vivenza, D and Messa, F and Milano, G and Merlano, M and Howe, K and Eustace, A and Souahli, S and Browne, B. C and Aherne, S and Barron, N and Walsh, N and Crown, J. P and O'Donovan, N and Mazzoni, F and Meoni, G and Cecere, F. L and Giuliani, C and Camerini, A and Allegrini, G and Martella, F and Boni, L and Torricelli, F and Di Costanzo, F and Rosell, R and Ramalingam, S. S and Fennell, D and Manegold, C and El Hariry, I and Vukovic, V and Teofilovici, F and Reichert, V and Goss, G and Laquente, B and Capdevila, J and Martinez-Villacampa, M and Lopez, C and Safont, M. J and Gomez, A and Manzano, J. L and Gravalos, C and Salazar, R and Aguilar, E. A and Takahashi, N and Yamada, Y and Taniguchi, H and Honma, Y and Iwasa, S and Kato, K and Hamaguchi, T and Shimada, Y and Torchio, M and Comolli, G and Danova, M and Mazzini, G and Formisano, L and Nappi, L and Rosa, R and Damiano, V and Marciano, R and D'Amato, C and Carlomagno, C and Troncone, G and De Placido, S and Bianco, R and Estepa, A. M. V and Canas, A and Nieto, V. H and Pedrera, C. L and Rodriguez, J. D. L. H and Ariza, A. R and Zoccoli, A and Iuliani, M and Pantano, F and Schiavon, G and Ratta, R and Correale, P and Muda, A. O and Santini, D and Tonini, G and Vincenzi, B and Spindler, K and Pallisgaard, N and Andersen, R and Jakobsen, A and Karachaliou, N and Costa, C and Gimenez-Capitan, A and Viteri, S and Gasco, A and Camps, C and Carcereny, E and Sureda, B. M and Souglakos, J and De Mattos-Arruda, L and ...
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix528 - ix540
Journal Article
by Clarke, S and Tan, C and Read, J and Phan, V and Peat, J. K and Beale, P and Gornadha, Y and Elaidi, R. T and Scotte, F and Vano, Y and Pecuchet, N and Gachet, J and Medioni, J and Fabre, E and Oudard, S and Freyer, G and Jovenin, N and Yazbek, G and Villanueva, C. B and Hussain, A and Bethune, A and Rotarski, M and Simon, H and Boulanger, V and Hummerlsberger, M and Gladkov, O. A and Bondarenko, I. M and Elsaesser, R and Buchner, A and Bias, P and Seligmann, J. F and Young, A and Heath, G and Cairns, D and Anthoney, A and Hall, G and Seymour, M and Swinson, D and Santini, D and Guida, F. M and Schiavon, G and Venditti, O and Frezza, A. M and Imperatori, M and Spoto, C and Berti, P and Vincenzi, B and Tonini, G and Del Mastro, L and Levaggi, A and Poggio, F and Giraudi, S and Bighin, C and D'Alonzo, A and Lambertini, M and Pronzato, P and Bruzzi, P and He, M and Huang, S and Yu, L and Shi, G and Deng, J and Zhang, X and Wang, X and Chen, J and Nong, X and Shen, P and Aarts, M. J and Grutters, J. P and Peters, F. P and Mandigers, C. M and Dercksen, M. W and Stouthard, J. M and Nortier, J. W and van Laarhoven, H. W and van Warmerdam, L. J and Tjan-Heijnen, V. C and Falandry, C and Krakowski, I and Cure, H and Carola, E and Soubeyran, P and Guerin, O and Aapro, M. S and Gascon, P and Ludwig, H and Bokemeyer, C and Boccadoro, M and Turner, M and Muenzberg, M and Denhaerynck, K and Abraham, I and Macdonald, K and Lotz, J and Tesch, H and Verpoort, K and Rosati, M. S and Salesi, N and Barker, H and Agrawal, S and ... and on behalf of BSMO/BHS and Lotuz Investigators
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix499 - ix527
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | CISPLATIN | ADENOCARCINOMA | PHASE-III | KINASE | ANAPLASTIC LYMPHOMA | QLQ-C30 | PLUS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Lung cancer | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Chemotherapy | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin
Journal Article
The Lancet Oncology, ISSN 1470-2045, 11/2017, Volume 18, Issue 11, pp. 1454 - 1466
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 10/2019, Volume 14, Issue 10, pp. 1818 - 1827
Introduction: Programmed death ligand 1 (PD-L1) expression is a predictive biomarker for patient response to nivolumab in nonsquamous NSCLC. However, the... 
Immunohistochemistry | ENDOBRONCHIAL ULTRASONOGRAPHY | ONCOLOGY | Biopsy | RESPIRATORY SYSTEM | Lung cancer | Immunotherapy | PD-L1 EXPRESSION | PD-L1 | TRANSBRONCHIAL NEEDLE ASPIRATION | DOCETAXEL
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2244 - 2250
PurposeARCHER 1050, a randomized, open-label, phase III study of dacomitinib versus gefitinib in treatment-naive patients with advanced non-small-cell lung... 
1ST-LINE TREATMENT | CONTROLLED-TRIAL | MULTICENTER | ONCOLOGY | ADENOCARCINOMA | PHASE-3 TRIAL | OPEN-LABEL | AFATINIB | INHIBITOR | CHEMOTHERAPY | ERLOTINIB
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 03/2017, Volume 139, Issue 12, pp. 4376 - 4389
In organisms, ion transporters play essential roles in the generation and dissipation of ion gradients across cell membranes. Microbial rhodopsins selectively... 
CHLORIDE PUMP HALORHODOPSIN | RETINYLIDENE SCHIFF-BASE | PURPLE MEMBRANE | RESONANCE RAMAN-SPECTROSCOPY | RETINAL CHROMOPHORE | ADAPTED BACTERIORHODOPSIN | VIBRATIONAL ANALYSIS | CHEMISTRY, MULTIDISCIPLINARY | SENSORY RHODOPSIN-I | NATRONOBACTERIUM-PHARAONIS | FEMTOSECOND SPECTROSCOPY
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Abstract Background Thymic carcinoma is a rare malignant disease. Standard treatments have not been established for patients with advanced or metastatic thymic... 
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2017, Volume 12, Issue 11, pp. S1754 - S1754
Journal Article
LUNG CANCER, ISSN 0169-5002, 03/2019, Volume 129, pp. 55 - 62
Objectives: This open-label, multicenter, phase lb/2 study assessed necitumumab plus gemcitabine and cisplatin (GC + N) in patients with previously untreated... 
Necitumumab | Gemcitabine | ONCOLOGY | RESPIRATORY SYSTEM | Japan | Non-small cell lung cancer | SQUIRE | EXPRESSION | Cisplatin | EGFR
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2017, Volume 12, Issue 11, pp. S2204 - S2205
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue suppl 9, pp. ix63 - ix63
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue suppl_4, pp. iv460 - iv461
Abstract Aim: A variety of targetable driver mutations other than EGFR mutations and ALK fusions occur in 1%-2% of non-small cell lung cancers (NSCLCs).... 
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 09/2014, Volume 9, Issue 9, pp. 1324 - 1331
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Abstract Background While atezolizumab, an anti-PD-L1 monoclonal antibody, is clinically effective against non-small cell lung cancer (NSCLC), its... 
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 625 - 9
Resistance to vandetanib, a type I RET kinase inhibitor, developed in a patient with metastatic lung adenocarcinoma harboring a CCDC6-RET fusion that initially... 
CELL LUNG-CANCER | MOLECULAR-DYNAMICS | PRECISION MEDICINE | FUSION | MODEL | MULTIDISCIPLINARY SCIENCES | Adenocarcinoma | Phenylalanine | Serine | Activation | Hydrophobicity | Drug resistance | Kinases | Metastases | Allosteric properties | Missense mutation | Lungs | Mutation | Crystal structure
Journal Article